OBVIOUS LOGIC”
“”
“The other obvious point is this: there is duplication among the young biopharma companies, and like any maturing industry, mergers, acquisitions, strategic alliances and collaborations are critical. I have not seen a lot of companies thinking seriously about this. The time is now!
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022